Author

Akulapalli Sudhakar

Observed names: A. Sudhakar, Sudhakar Akulapalli, Sudhakar, Akulapalli

Institutions: Creighton University, Boys Town National Research Hospital, University of Nebraska Medical Center

Observed institutions: Creighton University, Boys Town, Beth Israel Deaconess Medical Center, Howard Hughes Medical Institute, Harvard University, Baylor College of Medicine, University of Michigan, CHI Health Creighton University Medical Center - Bergan Mercy, University of Hyderabad, Boys Town National Research Hospital, Michigan Medicine, Dana-Farber Cancer Institute, National Institute of Immunology, University of Nebraska Medical Center

OpenAlex ID: A5083204349

Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing

2010 · Rohan Patil, Suranjana Das, et al. · PLoS ONE · 766

PDF

Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin

2003 · Yuki Hamano, Michael Zeisberg, et al. · Cancer Cell · 560

PDF

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

2003 · Hikaru Sugimoto, Yuki Hamano, et al. · Journal of Biological Chemistry · 538

History of Cancer, Ancient and Modern Treatment Methods

2009 · Akulapalli Sudhakar · Journal of Cancer Science & Therapy · 505

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins

2003 · Akulapalli Sudhakar, Hikaru Sugimoto, et al. · Proceedings of the National Academy of Sciences · 489

Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis

2002 · Yohei Maeshima, Akulapalli Sudhakar, et al. · Science · 437

Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors

2003 · Changqing Yang, Michael Zeisberg, et al. · Gastroenterology · 282

PDF

Differential Protein Expression Profiling by iTRAQ−2DLC−MS/MS of Lung Cancer Cells Undergoing Epithelial-Mesenchymal Transition Reveals a Migratory/Invasive Phenotype

2006 · Venkateshwar G. Keshamouni, George Michailidis, et al. · Journal of Proteome Research · 279

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

2002 · Hiroyasu Tsukaguchi, Akulapalli Sudhakar, et al. · Journal of Clinical Investigation · 234

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

2002 · Hiroyasu Tsukaguchi, Akulapalli Sudhakar, et al. · Journal of Clinical Investigation · 201

PDF

Phosphorylation of Serine 51 in Initiation Factor 2α (eIF2α) Promotes Complex Formation between eIF2α(P) and eIF2B and Causes Inhibition in the Guanine Nucleotide Exchange Activity of eIF2B

2000 · Akulapalli Sudhakar, Aruna Ramachandran, et al. · Biochemistry · 188

Thrombospondin-1 Associated with Tumor Microenvironment Contributes to Low-Dose Cyclophosphamide-Mediated Endothelial Cell Apoptosis and Tumor Growth Suppression

2004 · Yuki Hamano, Hikaru Sugimoto, et al. · Cancer Research · 185

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

2005 · Malin Sund, Yuki Hamano, et al. · Proceedings of the National Academy of Sciences · 179

Human 1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by 1 1 integrin

2005 · A. Sudhakar · Journal of Clinical Investigation · 162

PDF

Determinants of Vascular Permeability in the Kidney Glomerulus

2002 · Yuki Hamano, James A. Grunkemeyer, et al. · Journal of Biological Chemistry · 127

Characterization of the anti-angiogenic properties of arresten, an α1β1 integrin-dependent collagen-derived tumor suppressor

2008 · Pia Nyberg, Liang Xie, et al. · Experimental Cell Research · 99

Reduced DNA gap repair in aging rat neuronal extracts and its restoration by DNA polymerase β and DNA‐ligase

2005 · T. Hari Krishna, S. Mahipal, et al. · Journal of Neurochemistry · 60

RETRACTED ARTICLE: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression

2008 · Akulapalli Sudhakar, Chandra S. Boosani · Pharmaceutical Research · 58

PDF

Regulation of COX-2–mediated signaling by α3 type IV noncollagenous domain in tumor angiogenesis

2007 · Chandra Shekhar Boosani, Arjuna P. Mannam, et al. · Blood · 55

Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression

2010 · Rajendra K Singh, Akulapalli Sudhakar, et al. · Journal of Cancer Science & Therapy · 45

PDF

RETRACTED ARTICLE: Inhibitory Effects of Arresten on bFGF-Induced Proliferation, Migration, and Matrix Metalloproteinase-2 Activation in Mouse Retinal Endothelial Cells

2009 · Chandra Shekar Boosani, Narasimharao Nalabothula, et al. · Current Eye Research · 39

FAK and p38-MAP Kinase-Dependent Activation of Apoptosis and Caspase-3 in Retinal Endothelial Cells by α1(IV)NC1

2009 · Chandra S. Boosani, Narasimharao Nalabothula, et al. · Investigative Ophthalmology & Visual Science · 35

Cloning, purification, and characterization of a non-collagenous anti-angiogenic protein domain from human α1 type IV collagen expressed in Sf9 cells

2006 · Chandra Shekhar Boosani, Akulapalli Sudhakar · Protein Expression and Purification · 29

Signaling Mechanisms of Endogenous Angiogenesis Inhibitors Derived from Type IV Collagen

2007 · Akulapalli Sudhakar, Chandra S. Boosani · Gene Regulation and Systems Biology · 25

Serine 48 in Initiation Factor 2α (eIF2α) Is Required for High-Affinity Interaction between eIF2α(P) and eIF2B

1999 · Akulapalli Sudhakar, Thanuja Krishnamoorthy, et al. · Biochemistry · 25

Works count: 50

Citation count: 5,669

H-index: 25

I10-index: 28